The Expression and Significance of RKIP in Lung Squamous Cell Carcinoma Tissues

The Expression and Significance of RKIP in Lung Squamous Cell Carcinoma Tissues

Background and objective Raf kinase inhibitory protein (RKIP) belongs to the phosphatidylethanolamine binding protein (PEBP) family. RKIP is an endogenous inhibitor of the Raf-1-MEK1/2-ERK1/2 signaling pathway, NFkappaB signaling pathway and G protein coupled receptors signaling pathway. The aim of...

Full description

Bibliographic Details
Main Authors:	Haiyuan XU, Xin WANG, Wenxiang SHEN, Liqiang WANG, Gang SHEN, Minbin CHEN, Lina ZHOU
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-03-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms Raf kinase inhibitor protein Metastasis
Online Access:	http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.03.03&path[]=3664

Similar Items

Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer
by: Silvia Vivarelli, et al.
Published: (2022-02-01)

Expression and Significance of Raf Kinase Inhibitory Protein  in Lung Cancer
by: Dayun YANG, et al.
Published: (2012-10-01)

The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart
by: Joshua Abd Alla, et al.
Published: (2022-02-01)

Current Status of Akt in Non-small Cell Lung Cancer
by: Bojiang CHEN, et al.
Published: (2010-11-01)

Quantum chemical calculations, spectroscopic studies and molecular docking investigations of the anti-cancer drug quercitrin with B-RAF inhibitor
by: M. Govindammal, et al.
Published: (2022-05-01)

Florigen and its homologs of FT/CETS/PEBP/RKIP/YbhB family may be the enzymes of small molecule metabolism: review of the evidence
by: Olga Tsoy, et al.
Published: (2022-01-01)

A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression
by: Hiroaki Imoto, et al.
Published: (2023-08-01)

Approach to spot overlapping problem in 2D-PAGE revealed clinical and functional significance of RKIP and MnSOD in renal cell carcinoma
by: Noriyuki Hosoya, et al.
Published: (2014-09-01)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01)

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
by: Jakob Fleischmann, et al.
Published: (2021-03-01)

Genetic Fingerprint Concerned with Lymphatic Metastasis of Human Lung Squamous Cancer
by: Xiaolong ZHAO, et al.
Published: (2009-09-01)

Three-Pronged Approach to Curb Cancer Metastasis
by: Jariya Kalsoom, et al.
Published: (2023-02-01)

Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
by: Tarah Elizabeth Trebino, et al.
Published: (2023-12-01)

The expression and clinical significance of heparanase in non-small cell lung cancer
by: Zuoqing SONG, et al.
Published: (2008-12-01)

Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review
by: Yan XU, et al.
Published: (2017-05-01)

Investigation and Analysis of Primary Lung Cancer with Endotracheal and Endobronchial Metastases
by: Ming LU, et al.
Published: (2020-03-01)

Expression and clinical significance of MTA1 in non-small cell lung cancer
by: Dingbiao LI, et al.
Published: (2008-12-01)

Expression and Significance of MTA2 in Non-small Cell Lung Cancer
by: Shuhua WANG, et al.
Published: (2010-08-01)

Promotion of MAG-1 on Metastasis of Lung Cancer Cells in vitro and Its Expression in Lung Cancer Tissue of 24 Cases
by: Jinqiang ZHANG, et al.
Published: (2009-02-01)

Significance of Immunohistochemical Indicators in Diagnosis and Prognosis of  Squamous Cell Carcinoma and Adenocarcinoma of Lung
by: Yunfan MA, et al.
Published: (2014-06-01)

Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC
by: Lianfang NI, et al.
Published: (2018-05-01)

Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients
by: Delin QI, et al.
Published: (2020-05-01)

Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
by: Renhua GUO, et al.
Published: (2009-12-01)

Reduction of p120ctn isoforms is significantly associated with lymph node metastasis of lung cancer
by: Xinjun DONG, et al.
Published: (2008-08-01)

Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer
by: Shouzheng WANG, et al.
Published: (2016-10-01)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
by: Kristine Ø. Aasebø, et al.
Published: (2019-07-01)

Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase Inhibitor
by: Jing-Quan Wang, et al.
Published: (2020-12-01)

Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method
by: Qing LIU, et al.
Published: (2023-07-01)

MEK inhibitors for the treatment of non-small cell lung cancer
by: Jing Han, et al.
Published: (2021-01-01)

Research Progress of Immune Checkpoint Inhibitor Therapy for BRAF Mutation  in Non-small Cell Lung Cancer
by: Xia LIU, et al.
Published: (2019-09-01)

The Impact of Lung Carcinoma Histology on the Frequency of Bone Metastases
by: Marcelo Bragança dos Reis Oliveira, et al.

Research Progress of BRAF Fusion in Non-small Cell Lung Cancer
by: Ping XIAO, et al.
Published: (2023-10-01)

Research Progress of Small Molecule Anti-angiogenic Drugs  in Non-small Cell Lung Cancer
by: Yan DOU, et al.
Published: (2021-01-01)

Metastatic cancer mimics interstitial lung disease. Cases when we need fast diagnosis and treatment
by: Ana Hecimovic, et al.
Published: (2019-06-01)

Detection of CEA mRNA on non-small lung cancer and it's significance
by: Guowen WANG, et al.
Published: (2008-10-01)

Detection and Clinical Significance of Abundance of EGFR Mutation
by: Yi SHAO, et al.
Published: (2017-08-01)

Clinical Observation of EGFR-TKI as A First-line Therapy on Advanced Non-small Cell Lung Cancer
by: Jianjie LI, et al.
Published: (2012-05-01)

The Synergistic Cytotoxic Effects of GW5074 and Sorafenib by Impacting Mitochondrial Functions in Human Colorectal Cancer Cell Lines
by: Je-Ming Hu, et al.
Published: (2022-06-01)

Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells
by: Peilu Song, et al.
Published: (2022-06-01)

The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer
by: Baohui HAN, et al.
Published: (2009-12-01)